April 25, 2018 / 11:07 AM / a month ago

Currency weighs on GlaxoSmithKline Q1 sales and earnings

LONDON, April 25 (Reuters) - Drugmaker GlaxoSmithKline reported a 2 percent fall in both sales and earnings in the first quarter on Wednesday as a stronger pound offset a promising start for its new shingles vaccine Shingrix.

GSK’s adjusted earnings per share were 24.6 pence on sales of 7.22 billion pounds ($10.07 billion). Analysts, on average, had forecast 24.25 pence and 7.24 billion pounds, according to Thomson Reuters data. ($1 = 0.7168 pounds) (Reporting by Ben Hirschler, editing by Louise Heavens)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below